Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Antimicrobial Resistance & Infection Control
Published in: Antimicrobial Resistance & Infection Control 1/2018

Open Access 01-12-2018 | Review

Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review

Authors: M. H. F. Sakeena, Alexandra A. Bennett, Andrew J. McLachlan

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2018

Login to get access

Abstract

Background

Antimicrobial resistance (AMR) is a global health challenge and developing countries are more vulnerable to the adverse health impacts of AMR. Health care workers including pharmacists can play a key role to support the appropriate use of antimicrobials in developing countries and reduce AMR.

Objective

The aim of this review is to investigate the role of pharmacists in the appropriate use of antibiotics and to identify how the pharmacists’ role can be enhanced to combat AMR in developing countries.

Method

The databases MEDLINE, EMBASE, Web of Science and Google Scholar were searched for articles published between 2000 and the end of August 2017 that involved studies on the role of pharmacists in developing countries, the expanded services of pharmacists in patient care in developed countries and pharmacists’ contributions in antimicrobial use in both developed and developing nations.

Key findings

In developing countries pharmacists role in patient care are relatively limited. However, in developed nations, the pharmacists’ role has expanded to provide multifaceted services in patient care resulting in improved health outcomes from clinical services and reduced health care costs. Success stories of pharmacist-led programs in combating AMR demonstrates that appropriately trained pharmacists can be part of the solution to overcome the global challenge of AMR. Pharmacists can provide education to patients enabling them to use antibiotics appropriately. They can also provide guidance to their healthcare colleagues on appropriate antibiotic prescribing.

Conclusions

This review highlights that appropriately trained pharmacists integrated into the health care system can make a significant impact in minimising inappropriate antibiotic use in developing countries. Strengthening and enhancing the pharmacists’ role in developing countries has the potential to positively impact the global issue of AMR.
Literature
1.
Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. JAMA. 2016;316(11):1193–204.PubMed
2.
3.
Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med. 2016;13(3):e1001974.PubMedPubMedCentral
4.
Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005:5.
5.
Lee C-R, Cho IH, Jeong BC, Lee SH. Strategies to Minimize Antibiotic Resistance. Int J Environ Res Public Health. 2013;10(9):4274–305.PubMedPubMedCentral
6.
7.
Williford SL, Johnson DF. Impact of pharmacist counseling on medication knowledge and compliance. Mil Med. 1995;160(11):561–4.PubMed
8.
9.
Magedanz L, Silliprandi EM, dos Santos RP. Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study. Int J Clin Pharm. 2012;34(2):290–4.PubMed
10.
Booth JL, Mullen AB, Thomson DAM, Johnstone C, Galbraith SJ, Bryson SM, McGovern EM. Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study. Br J Gen Pract. 2013;63(609):e244–9.PubMedPubMedCentral
11.
Farley TM, Shelsky C, Powell S, Farris KB, Carter BL. Effect of clinical pharmacist intervention on medication discrepancies following hospital discharge. Int J Clin Pharm. 2014;36(2):430–7.PubMedPubMedCentral
12.
Awad A, Abahussain E. Health promotion and education activities of community pharmacists in Kuwait. Pharm World Sci. 2010;32(2):146–53.PubMed
13.
Ogbo PU, Aina BA, Aderemi-Williams RI. Management of acute diarrhea in children by community pharmacists in Lagos, Nigeria. Pharm Pract. 2014;12(1):376.
14.
Al-Niemat SI, Aljbouri TM, Goussous LS, Efaishat RA, Salah RK. Antibiotic prescribing patterns in outpatient emergency clinics at queen Rania Al Abdullah II Children’s hospital, Jordan, 2013. Oman Med J. 2014;29(4):250–4.PubMedPubMedCentral
15.
Ab Rahman N, Teng CL, Sivasampu S. Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia. BMC Infect Dis. 2016;16:208.PubMedPubMedCentral
16.
Shet A, Sundaresan S, Forsberg BC. Pharmacy-based dispensing of antimicrobial agents without prescription in India: appropriateness and cost burden in the private sector. Antimicrob Resist Infect Control. 2015;4(1):55.PubMedPubMedCentral
17.
Almaaytah A, Mukattash TL, Hajaj J. Dispensing of non-prescribed antibiotics in Jordan. Patient Prefer Adherence. 2015;9:1389–95.PubMedPubMedCentral
18.
Erku DA, Mekuria AB, Surur AS, Gebresillassie BM. Extent of dispensing prescription-only medications without a prescription in community drug retail outlets in Addis Ababa, Ethiopia: a simulated-patient study. Drug Healthc Patient Saf. 2016;8:65–70.PubMedPubMedCentral
19.
Chang J, Ye D, Lv B, Jiang M, Zhu S, Yan K, Tian Y, Fang Y. Sale of antibiotics without a prescription at community pharmacies in urban China: a multicentre cross-sectional survey. J Antimicrob Chemother. 2017;72(4):1235–42.PubMed
20.
Walia K, Ohri VC, Mathai D. Antimicrobial stewardship Programme of I: antimicrobial stewardship programme (AMSP) practices in India. Indian J Med Res. 2015;142(2):130–8.PubMedPubMedCentral
21.
Padget M, Guillemot D, Delarocque-Astagneau E. Measuring antibiotic consumption in low-income countries: a systematic review and integrative approach. Int J Antimicrob Agents. 2016;48(1):27–32.PubMed
22.
Miller R, Goodman C. Performance of retail pharmacies in low- and middle-income Asian settings: a systematic review. Health Policy Plan. 2016;31(7):940–53.PubMedPubMedCentral
23.
Fang Y, Yang S, Feng B, Ni Y, Zhang K. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health Soc Care Community. 2011;19(2):189–97.PubMed
24.
Hashmi FK, Hassali MA, Khalid A, Saleem F, Aljadhey H, Babar ZUD, Bashaar M. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore,Pakistan. BMC Health Serv Res. 2017;17(1):500.PubMedPubMedCentral
25.
Sancar M, Okuyan B, Apikoglu-Rabus S, Izzettin FV. Opinion and knowledge towards pharmaceutical care of the pharmacists participated in clinical pharmacy and pharmaceutical care continuing education program. Turkish J Pharmaceutical Sci. 2013;10(2):245–54.
26.
Kho BP, Hassali MA, Lim CJ, Saleem F. A qualitative study exploring professional pharmacy services offered by community pharmacies in the state of Sarawak, Malaysia. J Pharm Health Serv Res. 2017;8(3):201–8.
27.
Bilal AI, Tilahun Z, Gebretekle GB, Ayalneh B, Hailemeskel B, Engidawork E. Current status, challenges and the way forward for clinical pharmacy service in Ethiopian public hospitals. BMC Health Serv Res. 2017;17(1):359.PubMedPubMedCentral
28.
Salim AM, Elhada AH, Elgizoli B. Exploring clinical pharmacists’ perception of their impact on healthcare in Khartoum state, Sudan. J Res Pharm Pract. 2016;5(4):272–8.PubMedPubMedCentral
29.
Farina SS, Romano-Lieber NS. Pharmaceutical care in pharmacies: is there a changing process? Saúde e Sociedade. 2009;18:7–18.
30.
AbuRuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.PubMed
31.
Katoue MG, Awad AI, Schwinghammer TL, Kombian SB. Pharmaceutical care in Kuwait: hospital pharmacists’ perspectives. Int J Clin Pharm. 2014;36(6):1170–8.PubMed
32.
El Hajj MS, Al-Saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330–43.PubMed
33.
Brink AJ, Messina AP, Feldman C, Richards GA, Becker PJ, Goff DA, Bauer KA, Nathwani D, van den Bergh D. Antimicrobial stewardship across 47 south African hospitals: an implementation study. Lancet Infect Dis. 2016;16(9):1017–25.PubMed
34.
Zhou Y, Ma LY, Zhao X, Tian SH, Sun LY, Cui YM. Impact of pharmacist intervention on antibiotic use and prophylactic antibiotic use in urology clean operations. J Clin Pharm Ther. 2015;40(4):404–8.PubMed
35.
Shen J, Sun Q, Zhou X, Wei Y, Qi Y, Zhu J, Yan T. Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital. Int J Clin Pharm. 2011;33(6):929–33.PubMed
36.
Ellis K, Rubal-Peace G, Chang V, Liang E, Wong N, Campbell S. Antimicrobial stewardship for a geriatric behavioral health population. Antibiotics. 2016;5(1):8.PubMedPubMedCentral
37.
Okada N, Fushitani S, Azuma M, Nakamura S, Nakamura T, Teraoka K, Watanabe H, Abe M, Kawazoe K, Ishizawa K. Clinical evaluation of pharmacist interventions in patients treated with anti-methicillin-resistant Staphylococcus aureus agents in a hematological Ward. Biol Pharm Bull. 2016;39(2):295–300.PubMed
38.
Northey A, McGuren T, Stupans I. Patients’ antibiotic knowledge: a trial assessing the impact of verbal education. Int J Pharm Pract. 2015;23(2):158–60.PubMed
39.
Yen YH, Chen HY, Wuan-Jin L, Lin YM, Shen WC, Cheng KJ. Clinical and economic impact of a pharmacist-managed i.V.-to-p.O. conversion service for levofloxacin in Taiwan. Int J Clin Pharmacol Ther. 2012;50(2):136–41.PubMed
40.
Dunn K, O’Reilly A, Silke B, Rogers T, Bergin C. Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study. Int J Clin Pharm. 2011;33(2):208–14.PubMed
41.
Grill E, Weber A, Lohmann S, Vetter-Kerkhoff C, Strobl R, Jauch K-W. Effects of pharmaceutical counselling on antimicrobial use in surgical wards: intervention study with historical control group. Pharmacoepidemiol Drug Saf. 2011;20(7):739–46.PubMed
42.
Hersberger KE, Botomino A, Sarkar R, Tschudi P, Bucher HC, Briel M. Prescribed medications and pharmacy interventions for acute respiratory tract infections in Swiss primary care. J Clin Pharm Ther. 2009;34(4):387–95.PubMed
43.
Azhar S, Hassali MA, Ibrahim MIM, Ahmad M, Masood I, Shafie AA. The role of pharmacists in developing countries: the current scenario in Pakistan. Hum Resour Health. 2009;7(1):54.PubMedPubMedCentral
44.
45.
Fang Y, Yang S, Zhou S, Jiang M, Liu J. Community pharmacy practice in China: past, present and future. Int J Clin Pharm. 2013;35(4):520–8.PubMed
46.
Parthasarathi G, Ramesh M, Nyfort-Hansen K, Nagavi BG. Clinical pharmacy in a south Indian teaching hospital. Ann Pharmacother. 2002;36(5):927–32.PubMed
47.
Basak SC, van Mil JWF, Sathyanarayana D. The changing roles of pharmacists in community pharmacies: perception of reality in India. Pharm World Sci. 2009;31(6):612–8.PubMed
48.
Alanazi A, Alfadl A, Hussain A. Pharmaceutical care in the community pharmacies of Saudi Arabia: present status and possibilities for improvement. Saudi J Med Med Sci. 2016;4(1):9–14.PubMed
49.
Anderson S. The state of the world's pharmacy: a portrait of the pharmacy profession. J Interprof Care. 2002;16(4):391–404.PubMed
50.
Tumkur A, Muragundi PM, Shetty R, Naik A. Pharmaceutical care: need of the hour in India. J Young Pharm. 2012;4(4):282–6.PubMedPubMedCentral
51.
Khdour MR, Kidney JC, Smyth BM, McElnay JC. Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol. 2009;68(4):588–98.PubMedPubMedCentral
52.
Schimmelfing JT, Brookhart AL, Fountain KM, Goode JK. Pharmacist intervention in patient selection of nonprescription and self-care products. J Am Pharm Assoc (2003). 2017;57(1):86–9. e81PubMed
53.
Marra C, Johnston K, Santschi V, Tsuyuki RT. Cost-effectiveness of pharmacist care for managing hypertension in Canada. Can Pharm J (Ott). 2017;150(3):184–97.PubMed
54.
Krass I, Armour CL, Mitchell B, Brillant M, Dienaar R, Hughes J, Lau P, Peterson G, Stewart K, Taylor S, et al. The pharmacy diabetes care program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007;24(6):677–83.PubMed
55.
García-Cárdenas V, Sabater-Hernández D, Kenny P, Martínez-Martínez F, Faus MJ, Benrimoj SI. Effect of a pharmacist intervention on asthma control. A cluster randomised trial. Respir Med. 2013;107(9):1346–55.PubMed
56.
Hawksworth C, Wright C. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol. 1999;47(6):695–700.PubMedPubMedCentral
57.
Stewart DW, Brown SD, Clavier CW, Wyatt J. Active-learning processes used in US pharmacy education. Am J Pharm Educ. 2011;75(4):68.PubMed
58.
Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.PubMed
59.
Cabello-Muriel A, Gascon-Canovas JJ, Urbieta-Sanz E, Iniesta-Navalon C. Effectiveness of pharmacist intervention in patients with chronic kidney disease. Int J Clin Pharm. 2014;36(5):896–903.PubMed
60.
Tilly-Gratton A, Lamontagne A, Blais L, Bacon SL, Ernst P, Grad R, Lavoie KL, McKinney ML, Desplats E, Ducharme FM. Physician agreement regarding the expansion of pharmacist professional activities in the management of patients with asthma. Int J Pharm Pract. 2017;25(5):335–42.PubMed
61.
Hall JJ, Katz SJ, Cor MK. Patient satisfaction with pharmacist-led collaborative follow-up Care in an Ambulatory Rheumatology Clinic. Musculoskeletal Care. 2017;15(3):186–95.PubMed
62.
Proper JS, Wong A, Plath AE, Grant KA, Just DW, Dulhunty JM. Impact of clinical pharmacists in the emergency department of an Australian public hospital: a before and after study. Emerg Med Australas. 2015;27(3):232–8.PubMed
63.
Buurma H, De Smet PAGM, Leufkens HGM, Egberts ACG. Evaluation of the clinical value of pharmacists’ modifications of prescription errors. Br J Clin Pharmacol. 2004;58(5):503–11.PubMedPubMedCentral
64.
van Grootheest AC, de Jong-van den Berg LT. The role of hospital and community pharmacists in pharmacovigilance. Res Social Adm Pharm. 2005;1(1):126–33.PubMed
65.
Woolf R, Locke A, Potts C. Pharmacist prescribing within an integrated health system in Washington. Am J Health Syst Pharm. 2016;73(18):1416–624.PubMed
66.
Emmerton LM, Smith L, LeMay KS, Krass I, Saini B, Bosnic-Anticevich SZ, Reddel HK, Burton DL, Stewart K, Armour CL. Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Serv Res. 2012;12:164.PubMedPubMedCentral
67.
Keeys C, Kalejaiye B, Skinner M, Eimen M, Neufer J, Sidbury G, Buster N, Vincent J. Pharmacist-managed inpatient discharge medication reconciliation: a combined onsite and telepharmacy model. Am J Health Syst Pharm. 2014;71(24):2159–66.PubMed
68.
Milone AS, Philbrick AM, Harris IM, Fallert CJ. Medication reconciliation by clinical pharmacists in an outpatient family medicine clinic. J Am Pharm Assoc (2003). 2014;54(2):181–7.PubMed
69.
Eisenhower C. Impact of pharmacist-conducted medication reconciliation at discharge on readmissions of elderly patients with COPD. Ann Pharmacother. 2014;48(2):203–8.PubMed
70.
Castelino RL, Bajorek BV, Chen TF. Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index. Ann Pharmacother. 2010;44(12):1922–9.PubMed
71.
Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. Br Med J. 2001;323(7325):1340.
72.
Schuessler TJ, Ruisinger JF, Hare SE, Prohaska ES, Melton BL. Patient satisfaction with pharmacist-led chronic disease state management programs. J Pharm Pract. 2016;29(5):484–9.PubMed
73.
Awalom MT, Kidane ME, Abraha BW. Physicians’ views on the professional roles of pharmacists in patient care in Eritrea. Int J Clin Pharm. 2013;35(5):841–6.PubMed
74.
Laubscher T, Evans C, Blackburn D, Taylor J, McKay S. Collaboration between family physicians and community pharmacists to enhance adherence to chronic medications: opinions of Saskatchewan family physicians. Can Fam Physician. 2009;55(12):e69–75.PubMedPubMedCentral
75.
Khan MU, Arief M, Ahmad A, Malik S, Gogoi LJ, Kalita M, Saleem F, Hassali MAA. A cross-sectional survey on the attitudes and interests of rural population towards expanded pharmacist prescribing in India. Int J Clin Pharm. 2017;39(2):473–7.PubMed
76.
Sansgiry SS, Bhansali AH, Mhatre SK, Sawant RV. Influence of patient perceived relationship with pharmacist and physician and its association with beliefs in medicine. J Pharm Health Serv Res. 2017;8(2):123–30.
77.
Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm. 2013;19(5):408–16.PubMed
78.
Huttner B, Harbarth S, Nathwani D. Success stories of implementation of antimicrobial stewardship: a narrative review. Clin Microbiol Infect. 2014;20(10):954–62.PubMed
79.
Goff DA, Kullar R, Goldstein EJC, Gilchrist M, Nathwani D, Cheng AC, Cairns KA, Escandón-Vargas K, Villegas MV, Brink A, et al. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infect Dis. 2017;17(2):56–63.
80.
von Gunten V, Reymond JP, Beney J. Clinical and economic outcomes of pharmaceutical services related to antibiotic use: a literature review. Pharm World Sci. 2007;29(3):146–63.PubMed
81.
MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med. 2008;36(12):3184–9.PubMed
82.
Holmes AH, Sharland M. The Chennai declaration: India's landmark national commitment to antibiotic stewardship demonstrates that 'truth alone triumphs. J Antimicrob Chemother. 2013;68(7):1453–4.PubMed
83.
Sharma M, Damlin AL, Sharma A, Lundborg CS. Antibiotic prescribing in medical intensive care units - a comparison between two private sector hospitals in Central India. Infect Dis. 2015;47(5):302–9.
84.
Islam MS, Farah SS. Misleading promotion of drugs in Bangladesh: evidence from drug promotional brochures distributed to general practioners by the pharmaceutical companies. J Public Health. 2007;29(2):212–3.
85.
Parthasarathi G, Ramesh M, Kumar JK, Madaki S. Assessment of drug-related problems and clinical Pharmacists’ interventions in an Indian teaching hospital. J Pharm Pract Res. 2003;33(4):272–4.
86.
Dyar OJ, Beovic B, Vlahovic-Palcevski V, Verheij T, Pulcini C. How can we improve antibiotic prescribing in primary care? Expert Rev Anti Infect Ther. 2016;14(4):403–13.PubMed
87.
Azhar S, Hassali M, Ibrahim M. Doctors’ perception and expectations of the role of the pharmacist in Punjab, Pakistan. Trop J Pharm Res. 2010;9(3):205–22.
88.
Coombes I, Coombes J, Dawson A. Clinical pharmacy in Sri Lanka: translating training into practice. J Pharm Pract Res. 2015;45(4):392–3.
89.
Coombes ID, Fernando G, Wickramaratne DBM, Peters NB, Lynch C, Lum E, Coombes JA. Collaborating to develop clinical pharmacy teaching in Sri Lanka. Pharm Education. 2013;13:2013.
90.
Khan HMS, Butt H, Shah NH. PHP124 - exposure to potential drug-drug interactions in teaching hospital of South Punjab, Pakistan. Value Health. 2014;17(7):A425.PubMed
91.
Lingenfelter E, Drapkin Z, Fritz K, Youngquist S, Madsen T, Fix M. ED pharmacist monitoring of provider antibiotic selection aids appropriate treatment for outpatient UTI. Am J Emerg Med. 2016;34(8):1600-1603.
92.
LaRochelle JM, Ghaly M, Creel AM. Clinical pharmacy faculty interventions in a pediatric intensive care unit. J Investig Med. 2011;59(2):422–3.
93.
Roque F, Teixeira-Rodrigues A, Breitenfeld L, Pineiro-Lamas M, Figueiras A, Herdeiro MT. Decreasing antibiotic use through a joint intervention targeting physicians and pharmacists. Future Microbiol. 2016;11:877–86.PubMed
94.
Arya V, Pinto S, Singer J. Understanding awareness of pharmacist-led medication therapy management among primary care physicians in new York City, part II: findings and implications. J Med Pract Manage. 2013;29(3):187–94.PubMed
95.
Gupta A. Antimicrobial stewardship: think global, act local. Int J Infect Dis. 2014;21:74–5.
96.
Leguelinel-Blache G, Dubois F, Bouvet S, Roux-Marson C, Arnaud F, Castelli C, Ray V, Kinowski JM, Sotto A. Improving Patient’s primary medication adherence: the value of pharmaceutical counseling. Medicine. 2015;94(41):e1805.PubMedPubMedCentral
97.
Brink AJ, Messina AP, Feldman C, Richards GA, van den Bergh D. From guidelines to practice: A pharmacist-driven prospective audit and feedback improvement model for peri-operative antibiotic prophylaxis in 34 South African hospitals. J Antimicrob Chemother. 2017;72(4):1227–234.
Metadata
Title
Enhancing pharmacists’ role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review
Authors
M. H. F. Sakeena
Alexandra A. Bennett
Andrew J. McLachlan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2018
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-018-0351-z

Other articles of this Issue 1/2018

Antimicrobial Resistance & Infection Control 1/2018 Go to the issue

Research

Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study

Research

Prevalence of methicillin resistant Staphylococcus aureus, multidrug resistant and extended spectrum β-lactamase producing gram negative bacilli causing wound infections at a tertiary care hospital of Nepal

Research

Endemic carbapenem-nonsusceptible Acinetobacter baumannii-calcoaceticus complex in intensive care units of the national referral hospital in Jakarta, Indonesia

Research

Investigation of a Carbapenemase-producing Acinetobacter baumannii outbreak using whole genome sequencing versus a standard epidemiologic investigation

Research

Whole genome sequencing reveals high clonal diversity of Escherichia coli isolated from patients in a tertiary care hospital in Moshi, Tanzania

Research

Clostridium difficile infection perceptions and practices: a multicenter qualitative study in South Africa

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits